AHMED JANJUA: Open Payments
NPI 1912162728 · SYLVANIA, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$481 in 16 payments from 9 companies in 2025. Trend: 2023 $975 · 2024 $438 · 2025 $481
Food & beverage: $481
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $190 |
| Neurocrine BioSciences, Inc. | 2 | $102 |
| Alkermes, Inc. | 3 | $62 |
| ABBVIE INC. | 2 | $33 |
| Vanda Pharmaceuticals Inc. | 1 | $21 |
| Janssen Pharmaceuticals, Inc | 1 | $21 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
| HARMONY BIOSCIENCES LLC | 1 | $16 |
| Teva Pharmaceuticals USA, Inc. | 1 | $16 |
Products named: CAPLYTA, INGREZZA, ARISTADA, VRAYLAR, FANAPT, INVEGA SUSTENNA, REXULTI, WAKIX.
Industry payments across OH — which companies pay providers there.
